Erbitux
Erbitux ingredients
| Active ingredient | Strength |
|---|---|
| Cetuximab | 2 mg/mL |
What Erbitux is used for
The FDA lists the approved uses on the official label (below). In the EU, cetuximab is approved as Erbitux for:
Erbitux is indicated for the treatment of patients with epidermal growth factor receptor (EGFR)-expressing, RAS wild-type metastatic colorectal cancer: in combination with irinotecan-based chemotherapy; in first-line in combination with FOLFOX; as a single agent in patients who have failed oxaliplatin- and irinotecan-based therapy and who are intolerant to irinotecan. For details, see section 5.1. Erbitux is indicated for the treatment of adult patients with BRAF V600E mutant metastatic colorectal cancer: in combination with encorafenib and FOLFOX for the first line treatment; in combination with encorafenib in patients who have received prior systemic therapy. For details, see section 5.1, for biomarker-based patient selection, see section 4.2. Erbitux is indicated for the treatment of patients with squamous cell cancer of the head and neck: in combination with radiation therapy for loc…
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Erbitux
- Generic name
- Cetuximab
- Made by
- ImClone LLC
- Forms
- Solution
- Given
- Intravenous
- Drug class
- Epidermal Growth Factor Receptor Antagonist
- FDA approval
- Biologic licence (BLA) BLA125084
- On the US market since
- 2004
Official information
- Erbitux prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Cetuximab)
In India
- Cetuximab: 3 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Erbitux?
Erbitux (Cetuximab) is a cancer medicine made by ImClone LLC, approved by the US FDA.
What are the ingredients of Erbitux?
Erbitux contains Cetuximab (2 mg/mL).
Is Erbitux approved in Europe?
The same active substance is approved in the EU as Erbitux.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA